
GLP-1 Drugs: Obesity Treatment's New Frontier
The story in brief
New weight-loss medicines like Wegovy and Mounjaro have transformed obesity treatment for many, with Mounjaro's tirzepatide affecting appetite and blood sugar hormones. Obesity, a complex chronic condition, affects over 1 billion people globally. While these drugs are safe when used properly, long-term behavior change remains crucial for sustained weight management, as reliance on medication alone may not prevent cycles of weight loss and regain.